Search company, investor...

Predict your next investment

Venture Capital
sprucecp.com

Investments

22

Portfolio Exits

1

About Spruce Capital Partners

The principals and founders of Spruce Capital Partners, Dr. Ganesh Kishore, Dr. Roger Wyse, and Greg Young, are well known investors and thought leaders in the biogreentech sector. They bring a wealth of experience as investors, advisers, and domain experts in helping entrepreneurs build the next generation of successful biogreentech companies. They formed Spruce Capital Partners not only to manage venture funds, but also to develop new talent for the industry, provide thought leadership, and promote innovation in companies and countries. The principals have worked together for more than 10 years and have shepherded investments across multiple funds and multiple sectors. They are also active in advising, partnering, and shaping the life sciences industry globally and, especially in Malaysia and United States. Spruce Capital Partners is a co-manager of the MLS Capital Fund II. Additional information is available at www.sprucecp.com.

Headquarters Location

100 Montgomery St Suite 2190

San Francisco, California, 94103,

United States

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Expert Collections containing Spruce Capital Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Spruce Capital Partners in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Spruce Capital Partners News

Judge reopens tenants’ 421a rent overcharge suit against Muss

Jan 20, 2023

Housing Rights Initiative’s Aaron Carr and Muss Development’s Jason Muss (Facebook, Muss, Getty) A Supreme Court judge has reversed a dismissal of a 421a rent overcharge case, prompting tenants to claim the high ground in their war with city landlords over a murky area of the law. Landlords scored three favorable rulings last year that established owners did not need to report rent concessions to the state and could base future increases on a nondiscounted figure. But tenants organized by the nonprofit Housing Rights Initiative claimed they still had a card to play. Apartments are subject to rent stabilization while their buildings are receiving the 421a tax break. The issue is whether the legal rent — the basis for decades of future rent — should reflect initial concessions, which developers often grant if construction is not quite finished. Renters who brought a case against Spruce Capital Partners alleged the landlord had flouted 421a’s requirements by offering a one-time construction concession well after work had wrapped up. Spruce Capital wanted the complaint dismissed but a little over a year ago the Appellate Division denied the landlord’s request, kicking the case back to a lower court. “If the court assumes that the allegations set forth by plaintiffs are true … then they evidence a scheme to evade the requirements of the 421a program in order to charge higher rents,” the judge wrote. Now, a Supreme Court judge has applied the findings in the Spruce Capital suit to a similar case against Muss Development that had been tossed out in October 2021. Landlords had touted the Muss dismissal as validation of their position on 421a concessions. [/readmore] Justice Ingrid Joseph vacated her previous decision to dismiss the suit and reinstated the complaint to allow for discovery “to determine whether concessions were functionally equivalent to preferential rents,” legal documents show. Under the 2019 rent law, landlords must treat preferential rents — a price below the regulated rent — as the legal base rent for a unit when registering it with the state. Housing Rights Initiative founder Aaron Carr, who launched the investigation that spurred the suit, views the judge’s reversal of her own decision as significant. “This is extremely problematic for the landlords who hung their hat on the [Muss] decision and now find their hat on the floor,” Carr said. “This landlord’s skirting of its statutory obligations will now be subject to more formal scrutiny,” the tenants’ lawyers, Lucas Ferrara and Roger Sachar of Newman Ferrara, said in a joint statement. But Sherwin Belkin of Belkin Burden Goldman, the firm representing Muss Development and many other landlords in overcharge suits, said the reinstated complaint is small potatoes at most. “This merely allows discovery, but is not a decision on the merits,” Belkin said, comparing it to an outright win by landlords in late 2021 when a judge dismissed tenants’ overcharge claims against John Catsimatidis’ Red Apple Development. There is, though, an important difference between the Red Apple and Spruce Capital cases. In the former, a tenant received a free month construction rider while the building was still under a temporary certificate of occupancy, indicating that minor construction may have been ongoing. In Spruce, tenants claim construction was finished when concessions were offered. In reopening the Muss Development case, the judge noted that the Red Apple decision “taken together” with the Spruce ruling highlights “unless the landlord can present a justifiable reason for rent concessions, a tenant’s complaint should survive dismissal, and discovery should be allowed.” Still, the status of the Muss case may complicate matters for the tenants. Newman Ferrara had already appealed the Supreme Court’s decision to dismiss when the judge reversed that decision. As a result, Belkin’s team is appealing the decision to reinstate the complaint, arguing that the lower court judge abused her discretion by renewing an order pending review by a higher court that had already been briefed on the arguments. Contact Suzannah Cavanaugh

Spruce Capital Partners Investments

22 Investments

Spruce Capital Partners has made 22 investments. Their latest investment was in Inscripta as part of their Series E - III on January 1, 2023.

CBI Logo

Spruce Capital Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/18/2023

Series E - III

Inscripta

$27.79M

No

Undisclosed Investors

1

2/3/2022

PIPE

Greenlight Biosciences

$105M

No

1

2/8/2021

Series D

Infinant Health

$65M

No

2

2/8/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

1/25/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/18/2023

2/3/2022

2/8/2021

2/8/2021

1/25/2021

Round

Series E - III

PIPE

Series D

Series B

Seed VC

Company

Inscripta

Greenlight Biosciences

Infinant Health

Subscribe to see more

Subscribe to see more

Amount

$27.79M

$105M

$65M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Undisclosed Investors

Sources

1

1

2

10

10

Spruce Capital Partners Portfolio Exits

1 Portfolio Exit

Spruce Capital Partners has 1 portfolio exit. Their latest portfolio exit was Greenlight Biosciences on February 03, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/3/2022

Reverse Merger

$99M

3

Date

2/3/2022

Exit

Reverse Merger

Companies

Valuation

$99M

Acquirer

Sources

3

Spruce Capital Partners Team

3 Team Members

Spruce Capital Partners has 3 team members, including current Founder, Managing Partner, Roger E. Wyse.

Name

Work History

Title

Status

Roger E. Wyse

Founder, Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Roger E. Wyse

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Managing Partner

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.